Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Gains from Investment Securities (2010 - 2022)

Bio Key International recorded quarterly Gains from Investment Securities of $140000.0 in Q3 2022, up 150.05% quarter-over-quarter from $55989.0 in Q2 2020.

Bio Key International's Gains from Investment Securities history runs 11 years deep, the most recent figure standing at $140000.0 for Q3 2022.

  • In Q3 2022, Gains from Investment Securities changed N/A year-over-year to $140000.0; the TTM figure through Dec 2022 stood at $55989.0 (down 42.27% YoY), while the FY2022 annual figure was $186000.0, up 86.0% from the prior year.
  • Gains from Investment Securities came in at $140000.0 for Q3 2022 at Bio Key International, up from $55989.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $351918.0 in Q4 2018 to a low of $40995.0 in Q1 2020.
  • A 3-year average of $147225.5 and a median of $97994.5 in 2020 frame the typical range for Gains from Investment Securities.
  • On a YoY basis, Gains from Investment Securities climbed as much as 71.49% in 2018 and fell as far as 71.49% in 2018.
  • Bio Key International's Gains from Investment Securities stood at $351918.0 in 2018, then tumbled by 84.09% to $55989.0 in 2020, then jumped by 150.05% to $140000.0 in 2022.
  • According to Business Quant data, Gains from Investment Securities over the past three periods registered $140000.0, $55989.0, and $40995.0 for Q3 2022, Q2 2020, and Q1 2020 respectively.

Historic Data

Download Data 🔒
DateValue
Sep 30, 2022 140,000.00
Sep 30, 2022 140,000.00
Jun 30, 2020 55,989.00
Jun 30, 2020 55,989.00
Mar 31, 2020 40,995.00
Mar 31, 2020 40,995.00
Dec 31, 2018 351,918.00
Dec 31, 2018 351,918.00
Dec 31, 2017 1.23 Mn
Dec 31, 2017 1.23 Mn
Dec 31, 2016 247,280.00
Dec 31, 2016 247,280.00
Sep 30, 2016 275,000.00
Sep 30, 2016 275,000.00
Jun 30, 2016 75,000.00
Jun 30, 2016 75,000.00
Dec 31, 2015 364,930.00
Dec 31, 2015 364,930.00
Sep 30, 2015 1.18 Mn
Sep 30, 2015 1.18 Mn
Mar 31, 2015 75,000.00
Mar 31, 2015 75,000.00
Dec 31, 2014 341,277.00
Dec 31, 2014 341,277.00
Jun 30, 2014 3.42 Mn
Jun 30, 2014 3.42 Mn
Mar 31, 2014 3.42 Mn
Mar 31, 2014 3.42 Mn
Dec 31, 2013 2.70 Mn
Dec 31, 2013 2.70 Mn
Sep 30, 2013 2.35 Mn
Sep 30, 2013 2.35 Mn
Jun 30, 2013 2.35 Mn
Jun 30, 2013 2.35 Mn
Mar 31, 2013 2.30 Mn
Mar 31, 2013 2.30 Mn
Dec 31, 2012 1.63 Mn
Dec 31, 2012 1.63 Mn
Mar 31, 2012 1.13 Mn
Mar 31, 2012 1.13 Mn
Dec 31, 2011 4.40 Mn
Dec 31, 2011 4.40 Mn
Dec 31, 2010 4.41 Mn
Dec 31, 2010 4.41 Mn